AST/ALT Oranı

Klinik kullanımı:
AST/ALT oranları ile ilgili hastalıklar;
Hastalık AST/ALT Oranı
Alkolik karaciğer hastalığı 2,0 – > 6,0
Organik toksik hepatit > 2,0
Siroz 1,4 – 2,0
İntrahepatik kolestazis >1,5
Ekstrahepatik kolestazis <1,4
Kronik aktif hepatitis 1,3
Ekstrahepatik biliyer obstrüksiyon 0,8
Akut viral hepatit 0,5 – 0,8
Kaynaklar ve Referanslar
- [1]Xuan Y, Wu D, Zhang Q, et al. “Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States.”. Frontiers in endocrinology. 2024. PMID: 39253584. PubMed →
- [2]Kwo PY, Masuoka HC, Schaefer EA, Friedman LS. “Evaluation of Abnormal Liver Biochemical Test Results.”. Gastroenterology. 2026. PMID: 41831501. PubMed →
- [3]Amernia B, Moosavy SH, Banookh F, et al. “FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.”. BMC gastroenterology. 2021. PMID: 34861841. PubMed →
- [4]Baars T, Sowa JP, Neumann U, Hendricks S, Jinawy M, Kälsch J, Gerken G, Rassaf T, Heider D, Canbay A. “Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction.”. Archives of Medical Science. 2018. PMID: 32051708. PubMed →
- [5]Liu Y, Zhao P, Cheng M, et al. “AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study.”. Lipids in health and disease. 2018. PMID: 30509277. PubMed →


